NCT06613724View on ClinicalTrials.gov

Magnetic Duodeno-Ileal Chile Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

January 31, 2026

Conditions
ObesityType 2 Diabetes Mellitus (T2DM)
Interventions
DEVICE

Magnet System, DI Biofragmentable

Anastomoses achieved by magnetic compression.

Trial Locations (1)

Unknown

Clinica MEDS La Dehesa SpA, Santiago

Sponsors
All Listed Sponsors
lead

GT Metabolic Solutions, Inc.

INDUSTRY

NCT06613724 - Magnetic Duodeno-Ileal Chile Study | Biotech Hunter | Biotech Hunter